IDEXX Laboratories (IDXX) PT Raised to $580 at Leerink Partners

Leerink Partners analyst Daniel Clark raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $580.00 (from $515.00) while maintaining a Outperform rating.

The analyst comments "IDEXX Laboratories is the largest player in the veterinarian testing space, enjoying a dominant market share and robust growth profile. The company’s core offering of companion animal testing products and services has become an integral part of the vet office in terms of both workflow and profitability. Its steady rollout of new equipment and tests, coupled with test utilization and price increases, has driven what has been and should continue to be the strongest growth story in animal health. Although a portion of revenue growth is tied to visit volumes, which are out of the company’s control, we feel positive about their long-term trend, as pet ownership levels remain robust and as owners continue to increase their focus and spending on pet wellness and overall health. We rate IDEXX Outperform."

You May Also Be Interested In

• American Eagle Outfitters (AEO) PT Lowered to $16 at TD Cowen
• Crude Inventory 0.4M Barrels Last Week - EIA
• The Vita Coco Co. Inc (COCO) PT Lowered to $83; Piper Sandler: 'Pullback Is Overdone'